Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Block listing Interim Review

6 Sep 2019 07:00

RNS Number : 3959L
Mereo BioPharma Group plc
06 September 2019
 

Mereo BioPharma Group plc

 

Block Listing Interim Review

 

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies, Mereo BioPharma Group plc makes the following update on its block listing:

 

Date: 6 September 2019

 

Name of applicant:

Mereo BioPharma Group plc

Name of scheme:

2015 Plan

Mereo BioPharma Group plc Share Option Plan

Period of return:

From:

06/03/19

To:

06/09/19

Balance of unallotted securities under scheme(s) from previous return:

7,565,929

Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0

Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

0

Equals: Balance under scheme(s) not yet issued/allotted at end of period:

7,565,929

 

Name of contact:

Charles Sermon

Telephone number of contact:

+44 (0)333 023 7300

 

(Note: Italicised terms have the same meaning as given in the Listing Rules.)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BLRMMGGLFKGGLZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.